These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32093730)

  • 1. Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency.
    Pritchard AB; Strong A; Ficicioglu C
    Orphanet J Rare Dis; 2020 Feb; 15(1):58. PubMed ID: 32093730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome of a patient with lysosomal acid lipase deficiency and first results after initiation of treatment with Sebelipase alfa: A case report.
    Soll D; Spira D; Hollstein T; Haberbosch L; Demuth I; Steinhagen-Thiessen E; Bobbert T; Spranger J; Kassner U
    Mol Genet Metab Rep; 2019 Sep; 20():100479. PubMed ID: 31249784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency.
    Erwin AL
    Therap Adv Gastroenterol; 2017 Jul; 10(7):553-562. PubMed ID: 28804516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies.
    Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA
    Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sebelipase alfa: enzymatic replacement treatment for lysosomal acid lipase deficiency.
    Paton DM
    Drugs Today (Barc); 2016 May; 52(5):287-93. PubMed ID: 27376161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood/adult-onset lysosomal acid lipase deficiency: A serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases.
    Poinsot P; Collardeau Frachon S; Restier L; Sérusclat A; Di Filippo M; Charrière S; Moulin P; Lachaux A; Peretti N
    J Clin Lipidol; 2017; 11(1):167-177.e3. PubMed ID: 28391883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.
    Ezgü F
    Expert Opin Drug Saf; 2022 Feb; 21(2):149-155. PubMed ID: 34664536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on lysosomal acid lipase deficiency: Diagnosis, treatment and patient management.
    Camarena C; Aldamiz-Echevarria LJ; Polo B; Barba Romero MA; García I; Cebolla JJ; Ros E
    Med Clin (Barc); 2017 May; 148(9):429.e1-429.e10. PubMed ID: 28285817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sebelipase alfa over 52 weeks reduces serum transaminases, liver volume and improves serum lipids in patients with lysosomal acid lipase deficiency.
    Valayannopoulos V; Malinova V; Honzík T; Balwani M; Breen C; Deegan PB; Enns GM; Jones SA; Kane JP; Stock EO; Tripuraneni R; Eckert S; Schneider E; Hamilton G; Middleton MS; Sirlin C; Kessler B; Bourdon C; Boyadjiev SA; Sharma R; Twelves C; Whitley CB; Quinn AG
    J Hepatol; 2014 Nov; 61(5):1135-42. PubMed ID: 24993530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency.
    Burton BK; Balwani M; Feillet F; Barić I; Burrow TA; Camarena Grande C; Coker M; Consuelo-Sánchez A; Deegan P; Di Rocco M; Enns GM; Erbe R; Ezgu F; Ficicioglu C; Furuya KN; Kane J; Laukaitis C; Mengel E; Neilan EG; Nightingale S; Peters H; Scarpa M; Schwab KO; Smolka V; Valayannopoulos V; Wood M; Goodman Z; Yang Y; Eckert S; Rojas-Caro S; Quinn AG
    N Engl J Med; 2015 Sep; 373(11):1010-20. PubMed ID: 26352813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study.
    Jones SA; Rojas-Caro S; Quinn AG; Friedman M; Marulkar S; Ezgu F; Zaki O; Gargus JJ; Hughes J; Plantaz D; Vara R; Eckert S; Arnoux JB; Brassier A; Le Quan Sang KH; Valayannopoulos V
    Orphanet J Rare Dis; 2017 Feb; 12(1):25. PubMed ID: 28179030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: Two infants treated with sebelipase alfa.
    Santos Silva E; Klaudel-Dreszler M; Bakuła A; Oliva T; Sousa T; Fernandes PC; Tylki-Szymańska A; Kamenets E; Martins E; Socha P
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):e77-e82. PubMed ID: 29705274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?
    Chora JR; Alves AC; Medeiros AM; Mariano C; Lobarinhas G; Guerra A; Mansilha H; Cortez-Pinto H; Bourbon M
    J Clin Lipidol; 2017; 11(2):477-484.e2. PubMed ID: 28502505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study.
    Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M
    J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal acid lipase deficiency: Expanding differential diagnosis.
    Valayannopoulos V; Mengel E; Brassier A; Grabowski G
    Mol Genet Metab; 2017; 120(1-2):62-66. PubMed ID: 27876313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early diagnosis of infantile-onset lysosomal acid lipase deficiency in the advent of available enzyme replacement therapy.
    Cohen JL; Burfield J; Valdez-Gonzalez K; Samuels A; Stefanatos AK; Yudkoff M; Pedro H; Ficicioglu C
    Orphanet J Rare Dis; 2019 Aug; 14(1):198. PubMed ID: 31412917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lysosomal acid lipase deficiency in children: our experience and a novel possibility of enzyme replacement therapy].
    Ramadža DP; Ćuk M; Zibar K; Barić M; Sarnavka V; Bilić K; Fumić K; Vuković J; Pušeljić S; Ćorić M; Padovan RŠ; Kralik M; Barić I
    Lijec Vjesn; 2015; 137(3-4):81-7. PubMed ID: 26065284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency.
    Maciejko JJ
    Am J Cardiovasc Drugs; 2017 Jun; 17(3):217-231. PubMed ID: 28197978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Lysosomal Acid Lipase Deficiency Confirmed by Response to Sebelipase Alfa Therapy.
    Shen JJ; Davis JL; Hong X; Laningham FH; Gelb MH; Kim GE
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):726-730. PubMed ID: 32740531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency.
    Wilson DP; Friedman M; Marulkar S; Hamby T; Bruckert E
    J Clin Lipidol; 2018; 12(3):604-614. PubMed ID: 29628368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.